Kiwako Yamamoto-Hanada1, Masaki Futamura2, Limin Yang3, Tetsuo Shoda3, Masami Narita3, Fumio Kobayashi4, Hirohisa Saito5, Yukihiro Ohya6. 1. Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan. 2. Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Division of Pediatrics, Nagoya Medical Center, Nagoya, Aichi, Japan. 3. Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan. 4. Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan. 5. Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. 6. Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan. Electronic address: ohya-y@ncchd.go.jp.
Abstract
BACKGROUND: The prevalence of maternal oral contraceptive pills (OCP) use and that of childhood asthma are high in western countries. The aim of this study is to examine the association of OCP use with childhood wheeze and allergic diseases in Japan. METHODS: Relevant data were extracted from a hospital based birth cohort study named as Tokyo-Children's Health, Illness and Development Study (T-CHILD) of which questionnaire conducted during pregnancy included maternal history and duration of OCP use. To identify wheeze and allergic diseases in the children, the questionnaire of the International Study of Asthma and Allergies in Childhood (ISAAC) was used. Logistic regression models were applied to estimate those association and adjustments were made for maternal history of allergy, maternal education level, maternal age at pregnancy, maternal BMI, maternal smoking during pregnancy, mode of delivery, gestational age at delivery, daycare attendance, number of previous live births, and gender of child. RESULTS: OCP use was associated with ever wheeze (adjusted odds ratio [aOR], 1.62; 95% confidence interval [CI], 1.10-2.40), current wheeze (aOR, 1.59; 95% CI, 1.01-2.50), ever asthma (aOR, 1.65; 95% CI, 1.02-2.65), and ever rhinitis (aOR, 1.90; 95% CI, 1.30-2.80). Compared with no prior OCP use, using OCP for more than three months statistically increased the odds of ever wheeze (P = 0.012), current wheeze (P = 0.035), and ever rhinitis (P = 0.002). CONCLUSIONS: Our findings suggest that maternal OCP use has a role in the development of wheeze, asthma and rhinitis in children. Extended use of OCP is likely to increase the risk of wheeze and rhinitis.
BACKGROUND: The prevalence of maternal oral contraceptive pills (OCP) use and that of childhood asthma are high in western countries. The aim of this study is to examine the association of OCP use with childhood wheeze and allergic diseases in Japan. METHODS: Relevant data were extracted from a hospital based birth cohort study named as Tokyo-Children's Health, Illness and Development Study (T-CHILD) of which questionnaire conducted during pregnancy included maternal history and duration of OCP use. To identify wheeze and allergic diseases in the children, the questionnaire of the International Study of Asthma and Allergies in Childhood (ISAAC) was used. Logistic regression models were applied to estimate those association and adjustments were made for maternal history of allergy, maternal education level, maternal age at pregnancy, maternal BMI, maternal smoking during pregnancy, mode of delivery, gestational age at delivery, daycare attendance, number of previous live births, and gender of child. RESULTS: OCP use was associated with ever wheeze (adjusted odds ratio [aOR], 1.62; 95% confidence interval [CI], 1.10-2.40), current wheeze (aOR, 1.59; 95% CI, 1.01-2.50), ever asthma (aOR, 1.65; 95% CI, 1.02-2.65), and ever rhinitis (aOR, 1.90; 95% CI, 1.30-2.80). Compared with no prior OCP use, using OCP for more than three months statistically increased the odds of ever wheeze (P = 0.012), current wheeze (P = 0.035), and ever rhinitis (P = 0.002). CONCLUSIONS: Our findings suggest that maternal OCP use has a role in the development of wheeze, asthma and rhinitis in children. Extended use of OCP is likely to increase the risk of wheeze and rhinitis.
Authors: Merhunisa Talovic; Aziz Sheikh; Nicola McCleary; Maijaliisa Erkkola; Minna Kaila; Suvi M Virtanen; Bright I Nwaru Journal: BMJ Open Date: 2017-07-12 Impact factor: 2.692
Authors: Kiwako Yamamoto-Hanada; Magnus P Borres; Magnus K Åberg; Limin Yang; Tatsuki Fukuie; Masami Narita; Hirohisa Saito; Yukihiro Ohya Journal: World Allergy Organ J Date: 2020-02-25 Impact factor: 4.084
Authors: Juan Pablo López-Cervantes; Marianne Lønnebotn; Nils Oskar Jogi; Lucia Calciano; Ingrid Nordeide Kuiper; Matthew G Darby; Shyamali C Dharmage; Francisco Gómez-Real; Barbara Hammer; Randi Jacobsen Bertelsen; Ane Johannessen; Anne Mette Lund Würtz; Toril Mørkve Knudsen; Jennifer Koplin; Kathrine Pape; Svein Magne Skulstad; Signe Timm; Gro Tjalvin; Susanne Krauss-Etschmann; Simone Accordini; Vivi Schlünssen; Jorunn Kirkeleit; Cecilie Svanes Journal: Int J Environ Res Public Health Date: 2021-12-01 Impact factor: 3.390
Authors: Matthias V Kopp; Cathleen Muche-Borowski; Michael Abou-Dakn; Birgit Ahrens; Kirsten Beyer; Katharina Blümchen; Petra Bubel; Adam Chaker; Monika Cremer; Regina Ensenauer; Michael Gerstlauer; Uwe Gieler; Inga-Marie Hübner; Fritz Horak; Ludger Klimek; Berthold V Koletzko; Sybille Koletzko; Susanne Lau; Thomas Lob-Corzilius; Katja Nemat; Eva M J Peters; Antonio Pizzulli; Imke Reese; Claudia Rolinck-Werninghaus; Elien Rouw; Bianca Schaub; Sebastian Schmidt; Jens-Oliver Steiß; Anne Kathrin Striegel; Zsolt Szépfalusi; Dietmar Schlembach; Thomas Spindler; Christian Taube; Valérie Trendelenburg; Regina Treudler; Ulrich Umpfenbach; Christian Vogelberg; Martin Wagenmann; Anke Weißenborn; Thomas Werfel; Margitta Worm; Helmut Sitter; Eckard Hamelmann Journal: Allergol Select Date: 2022-03-04